Achaogen, inc. (AKAO)
CashFlow / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Cash flows from operating activities:
Net loss

-186,512

-125,618

-

-

-

-

-

Net loss

-

-

-71,227

-27,093

-20,176

-13,112

-18,365

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,553

1,334

441

426

358

506

565

Amortization of (discount) premium on short-term investments

341

227

-304

-500

-257

0

0

Stock-based compensation expense

14,410

14,172

3,847

2,983

-

-

-

Stock-based compensation expense

-

-

-

-

2,050

1,053

829

Loss on fixed asset disposals

-216

-54

-

-

-

-

-

Impairment relating to restructuring

14,044

-

-

-

-

-

-

Change in warrant and derivative liabilities

9,053

1,928

-

-

-

-

-

Revaluation of convertible preferred stock warrant

-

-

-

-

42

0

0

Change in warrant and derivative liabilities

-

-

19,859

19

-

-

-

Loss on debt extinguishment

-819

-

-

-

-

-

-

Loss on settlement of contingently redeemable common stock

-5,179

-

-

-

-

-

-

Change in derivative liability

-

-

-

-

-

0

-

Loss on asset disposition

-

-

-

-

-

-10

0

Non-cash interest expense relating to notes payable

862

847

741

302

209

472

524

Non-cash interest expense relating to related-party convertible loan payable

-

-

-

-

-

197

1,246

Non-cash restructuring charges

-

-

-

-

-

196

0

Change in operating assets and liabilities:
Trade and contract receivable, net

504

-10,794

-

-

-

-

-

Contracts receivable

-

-

7,112

-195

-1,996

2,972

-631

Prepaids and other assets

-4,955

4,107

199

1,504

-1,397

1,456

-98

Inventory

4,861

-

-

-

-

-

-

Other long-term assets

9,190

-

-

-

-

-

-

Accounts payable and accrued liabilities

691

5,736

6,668

3,076

-539

1,450

-1,911

Deferred revenue

-2,100

2,100

-

-

-

-

-

Other liabilities

3,832

1,588

-225

8

123

-198

-379

Net cash used in operating activities

-165,000

-95,255

-

-

-

-

-

Cash flows from investing activities:
Net cash used in operating activities

-

-

-46,903

-21,088

-14,283

-13,854

-16,762

Purchase of property and equipment

9,036

7,106

901

606

340

110

568

Proceeds from sale of property and equipment

614

-

-

-

-

-

-

Purchase of short-term investments

58,101

121,796

30,961

41,851

45,087

-

-

Purchase of short-term investments

-

-

-

-

-

0

0

Maturities of short-term investments

78,014

129,370

42,230

47,689

-

0

-

Net cash provided by investing activities

11,491

468

-

-

-

-

-

Cash flows from financing activities:
Change in restricted cash

-

-

-

-

-

-

-35

Net cash used in investing activities

-

-

10,368

5,232

-45,427

-110

-533

Proceeds from initial public offering, net of issuance costs

-

-

-

-

73,936

0

0

Proceeds from underwritten public offering, net of issuance costs

-

121,192

94,852

-

-

-

-

Proceeds from issuance of contingently redeemable common stock

-

10,000

-

-

-

-

-

Proceeds from private placement, net of issuance costs

-

-

25,166

-

-

-

-

Proceeds from issuance of convertible preferred stock, net of issuance costs

-

-

-

-

-

22,200

0

Proceeds from sales of common stock, net of issuance costs

31,416

-

3,827

1,319

-

0

-

Proceeds from issuance of related-party convertible notes payable

-

-

-

-

-

-

2,687

Proceeds from the issuance of common stock in connection with equity incentive plans

2,995

2,968

466

1,353

811

61

174

Proceeds from exercise of stock warrants

-

418

1,151

-

2

0

0

Proceeds from loan payable, net of issuance costs

49,189

-

10,000

14,590

-

0

-

Repurchase of contingently redeemable common stock

5,737

-

-

-

-

-

-

Repayment of loan payable

22,833

4,167

-

-

-

-

-

Net cash provided by financing activities

55,030

130,411

-

-

-

-

-

Net increase (decrease) in cash, cash equivalents, and restricted cash

-98,479

35,624

-

-

-

-

-

Proceeds from issuance of related-party convertible loan payable

-

-

-

-

-

-

2,445

Proceeds from issuance of notes payable

-

-

-

-

-

-

7,996

Repayment of notes payable

-

-

-

-

6,896

4,632

1,462

Net cash provided by financing activities

-

-

135,462

17,262

67,853

17,629

11,840

Net increase in cash, cash equivalents, and restricted cash

-

-

98,927

1,406

8,143

-

-

Supplemental disclosures of cash flow information
Interest paid

1,219

2,008

-

-

-

-

-

Interest paid

-

-

1,579

396

221

693

699

Net increase in cash and cash equivalents

-

-

-

-

-

3,665

-5,455

Supplemental disclosures of noncash investing and financing information
Conversion of convertible preferred stock into common stock

-

-

-

-

132,278

-

-

Reclassification of warrant liability to additional paid-in capital

-

2,088

8,337

-

286

0

0

Accrued and deferred public offering issuance cost

-

-

305

-

-

-

-

Issuance of derivative in connection with issuance of loan payable

-

-

-

356

-

-

-

Purchases of property and equipment included in accounts payable and accrued liabilities

-

1,130

-

-

-

-

-

Purchases of property and equipment included in deferred rent

1,485

4,701

1,896

-

-

-

-

Transfers of assets held for sale

1,509

-

-

-

-

-

-

Conversion of related-party convertible loan and notes payable to convertible preferred stock

-

-

-

-

-

9,724

0

Conversion of convertible preferred stock into common stock

-

-

-

-

-

0

0

Reclassification of warrant liability to additional paid-in capital

-

2,088

8,337

-

-

0

0